Molecule in python blood could pave way for new obesity drugs, scientists say

Researchers find snake metabolite that suppresses appetite of obese mice ‘without some of side-effects’ of GLP-1 drugs

Molecule in python blood could pave way for new obesity drugs, scientists say

TL;DR

  • Scientists have discovered a molecule called pTOS in the blood of pythons.
  • This molecule is produced by gut bacteria and spikes after the snakes consume a large meal.
  • When administered to obese mice, pTOS reduced their appetite and led to significant weight loss.
  • Unlike some current obesity drugs, pTOS appears to act on the hypothalamus in the brain to regulate appetite.
  • Researchers believe pTOS could be a basis for new obesity drugs with fewer side effects, as it occurs naturally in humans.
  • The study was inspired by pythons' ability to consume large prey and survive long periods without eating, a feat involving extreme metabolic changes.